mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant.
Gruell H, Vanshylla K, Tober-Lau P, Hillus D, Schommers P, Lehmann C, Kurth F, Sander LE, Klein F. · 2022
Read mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. by Gruell H, Vanshylla K, Tober-Lau P, Hillus D, Schommers P, Lehmann C, Kurth F, Sander LE, Klein F. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8767537.txt.
Description
Gruell and co-authors show that mRNA booster shots restore strong serum activity against the Omicron variant. Omicron carries an unusual load of mutations in antibody target sites. The team tested blood from vaccinated and recovered people over time. Lab-made virus assays measured how well each sample blocked Omicron.
Two doses of the Pfizer vaccine left near no blocking activity against Omicron. Blood from recovered people also failed in most cases. Several lab antibodies in clinical use lost their effect too. Booster shots changed the picture. Both vaccinated and recovered people gained strong blocking activity after an mRNA booster. The authors call boosters critical against this variant.
Catalog record
| CREATOR | Gruell H, Vanshylla K, Tober-Lau P, Hillus D, Schommers P, Lehmann C, Kurth F, Sander LE, Klein F. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |